Studies have shown that the role of MERTK in NF-κb signalling is twofold: in tumour cells, MERTK activates NF-κb to enhance survival signalling, whereas in myeloid immune cells, including macrophages, it inhibits NF-κb, which in turn inhibits the proinflammatory cytokine response. Here, MERTK is linked to neoplasm.